Co-Diagnostics, Inc. Quarterly Liabilities, Current in USD from Q4 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary
Co-Diagnostics, Inc. quarterly Liabilities, Current history and growth rate from Q4 2016 to Q3 2024.
  • Co-Diagnostics, Inc. Liabilities, Current for the quarter ending September 30, 2024 was $5.8M, a 13.7% increase year-over-year.
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $5.8M +$700K +13.7% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $5.31M +$190K +3.71% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $5.27M +$1.66M +46% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $5.75M +$1.87M +48.4% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $5.1M -$914K -15.2% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $5.12M -$1.6M -23.8% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $3.61M -$9.41M -72.3% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $3.87M -$8.72M -69.3% Dec 31, 2022 10-K 2024-03-14
Q3 2022 $6.01M +$1.89M +45.9% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $6.72M +$1.99M +42% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $13M +$8.71M +202% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $12.6M +$8.53M +210% Dec 31, 2021 10-K 2023-03-16
Q3 2021 $4.12M +$2.31M +127% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $4.73M +$1.74M +58.4% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $4.31M +$3.11M +261% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $4.06M +$3.73M +1138% Dec 31, 2020 10-K 2022-03-24
Q3 2020 $1.81M +$1.51M +489% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $2.98M +$2.67M +856% Jun 30, 2020 10-Q/A 2020-11-03
Q1 2020 $1.19M +$856K +254% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 $328K -$2.02M -86.1% Dec 31, 2019 10-K 2021-03-25
Q3 2019 $308K -$1.88M -85.9% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $312K +$21.5K +7.4% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $338K +$51.2K +17.9% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 $2.35M +$1.72M +274% Dec 31, 2018 10-K 2020-03-30
Q3 2018 $2.19M +$1.51M +223% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 $291K -$4.38M -93.8% Jun 30, 2018 10-Q 2018-08-10
Q1 2018 $286K Mar 31, 2018 10-Q 2018-05-14
Q4 2017 $628K -$3.22M -83.7% Dec 31, 2017 10-K 2019-04-01
Q3 2017 $677K Sep 30, 2017 10-Q 2017-11-14
Q2 2017 $4.67M Jun 30, 2017 10-Q 2017-08-25
Q4 2016 $3.85M Dec 31, 2016 10-K 2018-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.